United States Nephrology and Urology Devices Market Outlook to 2025 – Renal Dialysis Equipment

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995
Buy Report

Published: April 30, 2020 Report Code: GDMEMC0541DB-ST

Select Item

GlobalData’s “United States Nephrology and Urology Devices Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States Nephrology and Urology Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Renal Dialysis Equipment.

The United States Nephrology and Urology Devices Market report provides key information and data on:
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
• 2019 company share and distribution share data for Nephrology and Urology Devices Market.
• Global corporate-level profiles of key companies operating within the United States Nephrology and Urology Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States Nephrology and Urology Devices is segmented as follows:

• Renal Dialysis Equipment

Reasons to Buy

Key Reasons to Purchase – The United States Nephrology and Urology Devices Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Key companies covered in the “United States Nephrology and Urology Devices Market Outlook to 2025” report:
• Fresenius Medical Care AG & Co KGaA
• Baxter International Inc
• Nipro Corp

Table of Contents

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 6

2 Introduction 8

2.1 What Is This Report About? 8

2.2 Nephrology and Urology Devices Market Segmentation 8

2.3 Definitions of Markets Covered in the Report 9

3 Nephrology and Urology Devices Market, United States 11

3.1 Nephrology and Urology Devices Market, United States, Revenue ($m), 2015-2025 11

3.2 Nephrology and Urology Devices Market, United States, Revenue ($m), 2015-2025 13

3.3 Nephrology and Urology Devices Market, United States, Volume (Units), 2015-2025 15

3.4 Nephrology and Urology Devices Market, United States, Volume (Units), 2015-2025 17

3.5 Nephrology and Urology Devices Market, United States, Company Share by Revenue ($m), 2019 19

4 Renal Dialysis Equipment Market, United States 21

4.1 Renal Dialysis Equipment Market, United States, Revenue Mix ($m), 2019 21

4.2 Renal Dialysis Equipment Market, United States, Segment Contribution (%), 2019 22

4.3 Renal Dialysis Equipment Market, United States, Revenue ($m), 2015-2025 23

4.3.1 Dialysis Accessories Market, United States, Revenue ($m), by Segment, 2015-2025 25

4.3.2 Dialysis Machines Market, United States, Revenue ($m), by Segment, 2015-2025 28

4.3.3 Vascular Access Devices for Hemodialysis Market, United States, Revenue ($m), by Segment, 2015-2025 30

4.4 Renal Dialysis Equipment Market, United States, Volume (Units), 2015-2025 33

4.4.1 Dialysis Accessories Market, United States, Volume (Units) by Segment, 2015-2025 35

4.4.2 Dialysis Machines Market, United States, Volume (Units) by Segment, 2015-2025 38

4.4.3 Vascular Access Devices for Hemodialysis Market, United States, Volume (Units) by Segment, 2015-2025 40

4.5 Renal Dialysis Equipment Market, United States, Average Price ($), 2015-2025 43

4.6 Renal Dialysis Equipment Market, United States, Distribution Share by Revenue ($m), 2019 45

4.7 Renal Dialysis Equipment Market, United States, Company Share by Revenue ($m), 2019 46

5 Overview of Key Companies in United States, Nephrology and Urology Devices Market 48

5.1 Fresenius Medical Care AG & Co KGaA 48

5.1.1 Company Overview 48

5.2 Baxter International Inc 48

5.2.1 Company Overview 48

5.3 Nipro Corp 48

5.3.1 Company Overview 48

5.4 B. Braun Melsungen AG 49

5.4.1 Company Overview 49

5.5 CR Bard Inc 49

5.5.1 Company Overview 49

5.6 Asahi Kasei Corp 49

5.6.1 Company Overview 49

5.7 Toray Medical Co Ltd 50

5.7.1 Company Overview 50

5.8 Medtronic plc 50

5.8.1 Company Overview 50

6 Nephrology and Urology Devices Market Pipeline Products 51

7 Financial Deals Landscape 54

7.1 Acquisition 54

7.1.1 Laborie Medical Acquires Clinical Innovations 54

7.1.2 ICU Medical Acquires Pursuit Vascular 56

7.1.3 Merit Medical Acquires Brightwater Medical 57

7.1.4 Varian Medical Systems Acquires Endocare 58

7.2 Asset Transactions 59

7.2.1 Nipro Medical Acquires Dialysate Manufacturing Business from Dimesol USA 59

7.2.2 ConvaTec Group to Acquire Assets of Southlake Medical Supplies 60

7.2.3 IRRAS Acquires Assets and Intellectual Property of DermaPort from AMI-USC 61

7.3 Debt Offerings 62

7.3.1 Baxter International Raises USD500 Million in Private Placement of

3.95% Senior Notes Due 2030 62

7.3.2 Baxter International Raises USD750 Million in Private Placement of

3.75% Senior Notes Due 2025 63

7.3.3 Sientra Raises USD60 Million in Private Placement of Convertible Notes 64

7.3.4 Stryker Raises USD826.2 Million in Public Offering of 1% Notes Due 2031 66

7.3.5 Stryker Raises USD881.3 Million in Public Offering of

0.75% Notes Due 2029 68

7.3.6 Stryker Raises USD936.4 Million in Public Offering of

0.25% Notes Due 2024 70

7.3.7 Boston Scientific Raises USD999.2 Million in Public Offering of

0.625% Notes Due 2027 72

7.3.8 Mesa Laboratories Raises USD172.5 Million in Public Offering of

1.375% Convertible Senior Notes due 2025 74

7.3.9 Mesa Labs Raises USD172.5 Million in Public Offering of

1.375% Notes Due 2025 76

7.3.10 Dentsply Sirona to Raise USD116.98 Million in Private Placement of Series W

0.99% Senior Notes Due 2031 78

7.3.11 Rennova Health (CollabRx) Raises USD0.12 Million in Debt Funding 79

7.4 Equity Offerings 80

7.4.1 Immunic Therapeutics Plans to Raise up to USD15.84 Million in Public Offering of Shares 80

7.4.2 Aytu BioScience Prices Placement of Shares and Warrants for USD20 Million 81

7.4.3 Aethlon Medical Plans to Raise up to USD25 Million in Public Offering of Securities 82

7.4.4 Aethlon Medical to Raise up to USD7.5 Million in Public Offering of Shares 83

7.4.5 Aytu BioScience Prices Placement of Shares and Warrants for USD20 Million 85

7.4.6 Aytu BioScience Prices Placement of Shares for USD9 Million 86

7.4.7 Hancock Jaffe Labs Raises USD0.7 Million in Private Placement of Securities 87

7.4.8 Rockwell Medical Prices Public Offering of Shares for USD7.5 Million 88

7.4.9 Nephros Prices Public Offering of Shares for USD7.5 Million 90

7.4.10 NanoVibronix Files Registration Statement for Public Offering of Securities for up to USD11.9 Million 92

7.4.11 Aethlon Medical Raises USD3.8 Million in Private Placement of Shares and Warrants 94

7.4.12 Aethlon Medical Raises USD5 Million in Public Offering of Shares 96

7.4.13 Viveve Medical Raises USD10 Million in Public Offering of Units 98

7.4.14 Aytu BioScience to Raise USD10 Million in Private Placement of Preferred Shares and Warrants 100

7.4.15 Viveve Medical Files Registration Statement for Public Offering of Units for up to USD8 Million 102

7.4.16 Mesa Laboratories Raises USD90.6 Million in Public Offering of Common Stock 104

7.4.17 Mesa Labs Raises USD90.6 Million in Public Offering of Shares 106

7.4.18 NanoVibronix Raises USD3.2 Million in Private Placement of Convertible Preferred Stock 108

7.4.19 Rockwell Medical Raises USD17.5 Million in Public Offering of Common Stock 109

7.4.20 Hancock Jaffe Laboratories Prices Public Offering of Shares for USD3.9 Million 111

7.4.21 Nephros to Raise USD2 Million in Private Placement of Shares 113

7.4.22 Aethlon Medical to Raise Up to USD1.25 Million Public Offering of Common Stock 114

7.4.23 Sientra Raises USD115 Million in Public Offering of Shares 115

7.5 Merger 117

7.5.1 Salter Labs and SunMed Holdings Merge 117

7.6 Partnerships 118

7.6.1 Olympus Enters into Distribution Agreement with Rocamed 118

7.6.2 CorTechs Labs and Imaging Biometrics Enter into Distribution Agreement 119

7.7 Private Equity 120

7.7.1 Osprey Medical to Raise up to USD9.4 Million in Entitlement Offer of CDI 120

7.7.2 Rockwell Medical to Raise USD15 Million in Private Financing 122

7.8 Venture Financing 123

7.8.1 Flow Forward Medical to Raise Funds through Venture Financing 123

7.8.2 US Kidney Research Raises USD0.5 Million in Venture Financing 124

7.8.3 Outset Medical Raises USD125 Million in Series E Financing 125

7.8.4 Solace Therapeutics Raises USD4 Million in Venture Financing 127

7.8.5 Kyra Medical Raises USD0.1 Million in Venture Financing 128

7.8.6 Kyra Medical Raises USD0.16 Million in Venture Financing 129

7.8.7 SonoMotion Raises USD10 Million in Series B Financing 130

7.8.8 Pelvital USA Raises USD1 Million in Venture Financing 132

7.8.9 Kalera Medical Raises Funds through Venture Financing 133

7.8.10 Healionics Raises USD4.5 Million in Financing Round 134

7.8.11 MediBeacon Raises USD34.3 Million in Venture Financing 135

7.8.12 Renalert Raises Funds through Venture Financing 136

7.8.13 VenoStent Raises USD0.3 Million in Venture Financing 137

7.8.14 Corinth MedTech Raises USD12 Million in Series D Financing 138

7.8.15 Diality Raises USD10 Million in Series A Financing 139

7.8.16 Kyra Medical Raises USD0.2 Million in Venture Financing 140

7.8.17 Vesiflo Raises USD0.1 Million in Venture Financing 141

7.8.18 ClearFlow Raises USD7.6 Million in Venture Financing 142

7.8.19 Kalera Medical Raises USD0.5 Million in Venture Financing 143

7.8.20 Sonomotion Raises USD3.3 Million in Venture Financing 144

7.8.21 HistoSonics Raises USD54 Million in Series C Financing 145

8 Appendix 147

8.1 Research Methodology 148

8.1.1 Coverage 148

8.1.2 Secondary Research 148

8.1.3 Primary Research 149

8.1.4 Market Modeling and Forecasting 149

8.1.5 Company Share Analysis 151

8.1.6 Distribution Share Analysis 151

8.1.7 Benchmarking 152

8.2 GlobalData Consulting 152

8.3 Contact Us 153

8.4 Disclaimer 153

Table

1.1 List of Tables

Table 1: Nephrology and Urology Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 12

Table 2: Nephrology and Urology Devices Market, United States, Revenue ($m), USD Constant, 2015-2020 14

Table 3: Nephrology and Urology Devices Market, United States, Revenue ($m), USD Constant, 2021-2025 14

Table 4: Nephrology and Urology Devices Market, United States, Volume (Units), 2015-2025 16

Table 5: Nephrology and Urology Devices Market, United States, Volume (Units), 2015-2020 18

Table 6: Nephrology and Urology Devices Market, United States, Volume (Units), 2021-2025 18

Table 7: Nephrology and Urology Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2019 20

Table 8: Renal Dialysis Equipment Market, United States, Segment Contribution (%), 2019 22

Table 9: Renal Dialysis Equipment Market, United States, Revenue ($m), USD Constant, 2015-2020 24

Table 10: Renal Dialysis Equipment Market, United States, Revenue ($m), USD Constant, 2021-2025 24

Table 11: Dialysis Accessories Market, United States, Revenue ($m), USD Constant, 2015-2020 26

Table 12: Dialysis Accessories Market, United States, Revenue ($m) USD Constant, 2021-2025 27

Table 13: Dialysis Machines Market, United States, Revenue ($m), USD Constant, 2015-2020 29

Table 14: Dialysis Machines Market, United States, Revenue ($m) USD Constant, 2021-2025 29

Table 15: Vascular Access Devices for Hemodialysis Market, United States, Revenue ($m), USD Constant, 2015-2020 31

Table 16: Vascular Access Devices for Hemodialysis Market, United States, Revenue ($m) USD Constant, 2021-2025 32

Table 17: Renal Dialysis Equipment Market, United States, Volume (Units), 2015-2020 34

Table 18: Renal Dialysis Equipment Market, United States, Volume (Units), 2021-2025 34

Table 19: Dialysis Accessories Market, United States, Volume (Units), 2015-2020 36

Table 20: Dialysis Accessories Market, United States, Volume (Units), 2021-2025 37

Table 21: Dialysis Machines Market, United States, Volume (Units), 2015-2020 39

Table 22: Dialysis Machines Market, United States, Volume (Units), 2021-2025 39

Table 23: Vascular Access Devices for Hemodialysis Market, United States, Volume (Units), 2015-2020 41

Table 24: Vascular Access Devices for Hemodialysis Market, United States, Volume (Units), 2021-2025 42

Table 25: Renal Dialysis Equipment Market, United States, Average Price ($), 2015-2020 43

Table 26: Renal Dialysis Equipment Market, United States, Average Price ($), 2021-2025 44

Table 27: Renal Dialysis Equipment Market, United States, Distribution Share by Revenue ($m), USD Constant, 2019 45

Table 28: Renal Dialysis Equipment Market, United States, Company Share by Revenue ($m), USD Constant, 2019 47

Table 29: Nephrology and Urology Devices Market Pipeline Products 51

Table 30: Laborie Medical Acquires Clinical Innovations 54

Table 31: ICU Medical Acquires Pursuit Vascular 56

Table 32: Merit Medical Acquires Brightwater Medical 57

Table 33: Varian Medical Systems Acquires Endocare 58

Table 34: Nipro Medical Acquires Dialysate Manufacturing Business from Dimesol USA 59

Table 35: ConvaTec Group to Acquire Assets of Southlake Medical Supplies 60

Table 36: IRRAS Acquires Assets and Intellectual Property of DermaPort from AMI-USC 61

Table 37: Baxter International Raises USD500 Million in Private Placement of 3.95% Senior Notes Due 2030 62

Table 38: Baxter International Raises USD750 Million in Private Placement of 3.75% Senior Notes Due 2025 63

Table 39: Sientra Raises USD60 Million in Private Placement of Convertible Notes 64

Table 40: Stryker Raises USD826.2 Million in Public Offering of 1% Notes Due 2031 66

Table 41: Stryker Raises USD881.3 Million in Public Offering of 0.75% Notes Due 2029 68

Table 42: Stryker Raises USD936.4 Million in Public Offering of 0.25% Notes Due 2024 70

Table 43: Boston Scientific Raises USD999.2 Million in Public Offering of 0.625% Notes Due 2027 72

Table 44: Mesa Laboratories Raises USD172.5 Million in Public Offering of 1.375% Convertible Senior Notes due 2025 74

Table 45: Mesa Labs Raises USD172.5 Million in Public Offering of 1.375% Notes Due 2025 76

Table 46: Dentsply Sirona to Raise USD116.98 Million in Private Placement of Series W 0.99% Senior Notes Due 2031 78

Table 47: Rennova Health (CollabRx) Raises USD0.12 Million in Debt Funding 79

Table 48: Immunic Therapeutics Plans to Raise up to USD15.84 Million in Public Offering of Shares 80

Table 49: Aytu BioScience Prices Placement of Shares and Warrants for USD20 Million 81

Table 50: Aethlon Medical Plans to Raise up to USD25 Million in Public Offering of Securities 82

Table 51: Aethlon Medical to Raise up to USD7.5 Million in Public Offering of Shares 83

Table 52: Aytu BioScience Prices Placement of Shares and Warrants for USD20 Million 85

Table 53: Aytu BioScience Prices Placement of Shares for USD9 Million 86

Table 54: Hancock Jaffe Labs Raises USD0.7 Million in Private Placement of Securities 87

Table 55: Rockwell Medical Prices Public Offering of Shares for USD7.5 Million 88

Table 56: Nephros Prices Public Offering of Shares for USD7.5 Million 90

Table 57: NanoVibronix Files Registration Statement for Public Offering of Securities for up to USD11.9 Million 92

Table 58: Aethlon Medical Raises USD3.8 Million in Private Placement of Shares and Warrants 94

Table 59: Aethlon Medical Raises USD5 Million in Public Offering of Shares 96

Table 60: Viveve Medical Raises USD10 Million in Public Offering of Units 98

Table 61: Aytu BioScience to Raise USD10 Million in Private Placement of Preferred Shares and Warrants 100

Table 62: Viveve Medical Files Registration Statement for Public Offering of Units for up to USD8 Million 102

Table 63: Mesa Laboratories Raises USD90.6 Million in Public Offering of Common Stock 104

Table 64: Mesa Labs Raises USD90.6 Million in Public Offering of Shares 106

Table 65: NanoVibronix Raises USD3.2 Million in Private Placement of Convertible Preferred Stock 108

Table 66: Rockwell Medical Raises USD17.5 Million in Public Offering of Common Stock 109

Table 67: Hancock Jaffe Laboratories Prices Public Offering of Shares for USD3.9 Million 111

Table 68: Nephros to Raise USD2 Million in Private Placement of Shares 113

Table 69: Aethlon Medical to Raise Up to USD1.25 Million Public Offering of Common Stock 114

Table 70: Sientra Raises USD115 Million in Public Offering of Shares 115

Table 71: Salter Labs and SunMed Holdings Merge 117

Table 72: Olympus Enters into Distribution Agreement with Rocamed 118

Table 73: CorTechs Labs and Imaging Biometrics Enter into Distribution Agreement 119

Table 74: Osprey Medical to Raise up to USD9.4 Million in Entitlement Offer of CDI 120

Table 75: Rockwell Medical to Raise USD15 Million in Private Financing 122

Table 76: Flow Forward Medical to Raise Funds through Venture Financing 123

Table 77: US Kidney Research Raises USD0.5 Million in Venture Financing 124

Table 78: Outset Medical Raises USD125 Million in Series E Financing 125

Table 79: Solace Therapeutics Raises USD4 Million in Venture Financing 127

Table 80: Kyra Medical Raises USD0.1 Million in Venture Financing 128

Table 81: Kyra Medical Raises USD0.16 Million in Venture Financing 129

Table 82: SonoMotion Raises USD10 Million in Series B Financing 130

Table 83: Pelvital USA Raises USD1 Million in Venture Financing 132

Table 84: Kalera Medical Raises Funds through Venture Financing 133

Table 85: Healionics Raises USD4.5 Million in Financing Round 134

Table 86: MediBeacon Raises USD34.3 Million in Venture Financing 135

Table 87: Renalert Raises Funds through Venture Financing 136

Table 88: VenoStent Raises USD0.3 Million in Venture Financing 137

Table 89: Corinth MedTech Raises USD12 Million in Series D Financing 138

Table 90: Diality Raises USD10 Million in Series A Financing 139

Table 91: Kyra Medical Raises USD0.2 Million in Venture Financing 140

Table 92: Vesiflo Raises USD0.1 Million in Venture Financing 141

Table 93: ClearFlow Raises USD7.6 Million in Venture Financing 142

Table 94: Kalera Medical Raises USD0.5 Million in Venture Financing 143

Table 95: Sonomotion Raises USD3.3 Million in Venture Financing 144

Table 96: HistoSonics Raises USD54 Million in Series C Financing 145

Figures

1.2 List of Figures

Figure 1: Nephrology and Urology Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 11

Figure 2: Nephrology and Urology Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 13

Figure 3: Nephrology and Urology Devices Market, United States, Volume (Units), 2015-2025 15

Figure 4: Nephrology and Urology Devices Market, United States, Volume (Units), 2015-2025 17

Figure 5: Nephrology and Urology Devices Market, United States, Company Share (%) 2019 19

Figure 6: Renal Dialysis Equipment Market, United States, Revenue Mix ($m), 2019 21

Figure 7: Renal Dialysis Equipment Market, United States, Segment Contribution (%), 2019 22

Figure 8: Renal Dialysis Equipment Market, United States, Revenue ($m), USD Constant, 2015-2025 23

Figure 9: Dialysis Accessories Market, United States, Revenue ($m), USD Constant, 2015-2025 25

Figure 10: Dialysis Machines Market, United States, Revenue ($m), USD Constant, 2015-2025 28

Figure 11: Vascular Access Devices for Hemodialysis Market, United States, Revenue ($m), USD Constant, 2015-2025 30

Figure 12: Renal Dialysis Equipment Market, United States, Volume (Units), 2015-2025 33

Figure 13: Dialysis Accessories Market, United States, Volume (Units), 2015-2025 35

Figure 14: Dialysis Machines Market, United States, Volume (Units), 2015-2025 38

Figure 15: Vascular Access Devices for Hemodialysis Market, United States, Volume (Units), 2015-2025 40

Figure 16: Renal Dialysis Equipment Market, United States, Company Share (%) 2019 46

Frequently asked questions

United States Nephrology and Urology Devices Market Outlook to 2025 – Renal Dialysis Equipment standard reports
Currency USD
$5,995

Can be used by individual purchaser only

Most Popular
$11,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Nephrology and Urology Devices reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at United States Nephrology and Urology Devices Market Outlook to 2025 – Renal Dialysis Equipment in real time.

  • Access a live United States Nephrology and Urology Devices Market Outlook to 2025 – Renal Dialysis Equipment dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more